Woodlands Online, LLC Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare and ... MarketWatch (press release) Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA (R) (exenatide) ... Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare and ...

Crossing the Biotech 'Valley of Death': From Innovation to Cure Seeking Alpha (blog) These include Byetta , Copaxone, Geldanamycin, Emtriva, Alimta, Taxol, and Rapamycin. But the process of translating a laboratory discovery into a drug is ...

The Star-Ledger - NJ.com Novo Nordisk takes a big risk with new diabetes research The Star-Ledger - NJ.com The San Diego-based drugmaker, which partnered with Eli Lilly, beat Novo Nordisk to market with Byetta , the first drug in the GLP-1 class. ...

Lawyers and Settlements Health Concerns Partially Cause Byetta to Lose Ground in Diabetes Market Lawyers and Settlements Princeton, NJ: A new diabetes drug introduced earlier this year will likely challenge Eli Lilly's Byetta for control of the diabetes medication market. ...

Barclays Maintains an 'Overweight' Rating on Amylin Pharmaceuticals (AMLN ... StreetInsider.com (subscription) Barclays analys says,"IMS Health prescription data reported this morning suggests flat scrips sequentially for GLP-1 TRx and NRx, Byetta TRx and NRx, ...

Lawyers and Settlements " Byetta is a Bad Drug" Lawyers and Settlements Mobile, AL: Donald, 72, a retired attorney, a type 2 diabetic and a former Byetta user, says Byetta is not to be trusted. "I want to get the word out that ...

Puts Sold of Amylin Pharmaceuticals (AMLN) Benzinga The company is marketing two first-in-class medicines to treat diabetes, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection. ...

INTERVIEW: Novo Nordisk To Test Victoza In Anti-Obesity - CEO Wall Street Journal The once-daily injected product is just the second drug in the new-generation GLP-1 category, rivalling Byetta from Eli Lilly & Co. ...

Lawyers and Settlements A Potential New Market for Byetta ? Lawyers and Settlements Cincinatti, OH: Type 2 diabetes drug Byetta , thought to be associated with acute pancreatitis and various other side effects, may one day put at risk an ...

How a Pitch for Byetta's Diabetes Drug Actually Helped Its Competitors BNET (blog) Unfortunately, clinical data presented at the conference for their once-promising type-2 diabetes drug Byetta served only to reinforce current physician ...